Excellen Medical

Excellen Medical Technology Co., Ltd., a subsidiary of Lepu Medical (stock code: 300003) focusing on cancer detection, is a high-tech biomedical enterprise integrating the research, development, production, and sales of clinical diagnostic reagents and instruments, primarily guided by molecular diagnostic technology. The company has a full-cycle R&D and sales system. Excellen Medical has gathered top medical experts and owns multiple domestic and international invention patents. It has established extensive cooperation with leading academic institutions, hospitals, and enterprises both domestically and internationally, including the Chinese Academy of Sciences, Peking University, Cancer Hospital of the Chinese Academy of Medical Sciences, PLA General Hospital, Peking Union Medical College Hospital, West China Hospital, China-Japan Friendship Hospital, and Beijing Hospital. Excellen Medical will continue to focus on precise early detection and auxiliary diagnosis in asymptomatic populations, continuously promoting scientific research, clinical practice, and application transformation of early detection technologies, striving to serve the public and benefit society.